Viral Clearance Service Market

Viral Clearance Service Market (Method: Viral Removal and Viral Inactivation; and Application: Recombinant Proteins, Tissue and Blood-derived Products, Vaccines, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Viral Clearance Service Market Outlook 2031

  • The industry was valued at US$ 857.4 Mn in 2022
  • It is estimated to grow at a CAGR of 14.6% from 2023 to 2031 and reach 2.8 Bn by the end of 2031

Analyst Viewpoint

Rise in investment in biological testing and surge in production of biologics are fueling the viral clearance service market size. Virus detection plays a major role in the production of specialty drugs and biological products.

The viral clearance service market landscape is witnessing robust expansion owing to increase in complexity of clinical trials and implementation of stringent regulations in the biopharmaceutical sector.

Pharmaceutical companies are partnering with viral clearance service providers to ensure consistent and safe development of biological products.

Virus inactivation plays a crucial role in ensuring the safety of pharmaceutical molecules by eliminating the risk of viral contamination.

Thus, vendors are offering robust detergent treatments that disrupt the lipid membrane of enveloped viruses, leading to their inactivation, a pivotal step in viral clearance.

Market Introduction

Viral clearance services are critical to the validation of downstream processes. They ensure the clearance of potential adventitious viruses in the event of contamination.

These services are used to remove bacteria or viruses present in drugs, production equipment, or biological products. They include the testing of end-products. Viral clearance services ensure consistent and safe development of biological products.

Viral clearance services are employed in clinical phase I/III studies to check the feasibility or design of experiments studies. They are used to demonstrate the capability of a downstream purification process to eliminate potential viral contaminants.

Attribute Detail
Drivers
  • Rise in Investment in Biological Testing
  • Surge in Production of Biologics

Rise in Investment in Biological Testing Fueling Viral Clearance Service Market Revenue

Most biological products are derived from living cell cultures. This increases the risk of viral contamination in final products. Viral contamination is common in most animal- and human-derived biopharmaceuticals.

It can affect any part of the bioproduction process. Viral clearance services for biopharmaceuticals ensure that production processes are free from detectable adventitious agents.

Healthcare regulatory bodies across the globe mandate the use of viral clearance studies to demonstrate the capacity of the production process in viral removal and inactivation.

Thus, biopharmaceutical manufacturers need to perform viral testing studies and incorporate viral clearance methods into their processes. This, in turn, is propelling the viral clearance service market development.

Implementation of stringent regulatory guidelines regarding viral safety and viral clearance has led to the development of state-of-the-art detection technologies. These guidelines are critical to the biologics landscape and viral safety and are prompting investment in biosafety laboratories.

In November 2023, MilliporeSigma, Merck KGaA’s life science business, started the second phase of its new US$ 31.7 Mn Biologics Testing Center in China, adding 1,500 m2 to the lab opened in 2022.

Establishing such biosafety laboratories is contributing to the viral clearance service market growth and facilitating access to a broad range of testing services for cell line characterization and lot release from preclinical development to commercialization.

Surge in Production of Biologics Driving Market Progress

Viral safety is a critical aspect of biopharmaceutical/biologics production. Viral clearance services help prevent, detect, and remove any contamination to assure drug safety for patients. These services play a major role during the early stages of product development.

According to an analysis shared at the Convention on Pharmaceutical Ingredients (CPHI) in 2023, the biologics market is set for a substantial expansion, with demand expected to reach 4,400 kiloliters (KL) by 2027, up from 2,500 KL in 2022.

This significant growth comes with a yearly rate of increase of 11.5%, and concurrent capacity expansion to 8,400KL by 2027, up from 6,550KL in 2023. Thus, increase in production of biologics is boosting the viral clearance service market revenue.

Regional Outlook

Attribute Detail
Leading Region North America

According to the latest viral clearance service market analysis, North America held largest share in 2022. Presence of major viral clearance removal/inactivation service providers and implementation of stringent regulations governing the safety assessment of biologics and vaccines are fueling the market dynamics of the region.

In the U.S., the Food and Drug Administration (FDA) must approve a vaccine before it can be used in the country. FDA regulations for the development of vaccines and biologics help ensure their safety, purity, potency, and effectiveness.

Surge in investment in drug discovery and growth in preference for outsourcing viral clearance services are contributing to the viral clearance service market share in North America.

Rise in consumer awareness about the safety associated with the use of vaccines and biologics and increase in concern regarding the viral effects of blood-derived products are also boosting the demand for viral clearance services in the region.

Analysis of Key Players

Major players are providing Good Laboratory Practice (GLP)-grade viral clearance testing and viral safety services. They are also expanding their manufacturing capabilities to cater to the rise in demand. In 2023, Texcell established a new facility in China and expanded the facility in the U.S.

Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA, WuXi AppTec, Clean Cells, and Vironova Biosafety AB are key players operating in this viral clearance service industry.

Each of these companies has been profiled in the viral clearance service market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.

Key Developments in Viral Clearance Service Market

  • In December 2023, Summit Pharmaceuticals International Corporation signed an exclusive distributorship agreement with Texcell Japan, a France-based company providing certified cell-banking and biosafety services following Good Manufacturing Practices (GMP) or Good Laboratory Practices (GLP) for pharmaceuticals and biological products
  • In November 2023, Merck launched its innovative Deviron detergent portfolio designed to be more effective than conventional virus inactivation methods and to facilitate compliance with evolving regulatory standards

Viral Clearance Service Market Snapshot

Attribute Detail
Market Size in 2022 US$ 857.4 Mn
Market Forecast (Value) in 2031 US$ 2.8 Bn
Growth Rate (CAGR) 14.6%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • By Method
    • Viral Removal
    • Viral Inactivation
      • Chemical
      • Radiation
      • Others
  • By Application
    • Recombinant Proteins
    • Tissue and Blood-derived Products
    • Vaccines
    • Others
  • By End-user
    • Biopharmaceuticals
    • Contract Research Organizations
    • Academic Research Institutes
    • Others
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Texcell
  • Eurofins Scientific SE
  • Charles River Laboratories International, Inc.
  • Merck KGaA
  • WuXi AppTec
  • Clean Cells
  • Vironova Biosafety AB
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global viral clearance service market in 2022?

It was valued at US$ 857.4 Mn in 2022

How is the viral clearance service industry expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 14.6% from 2023 to 2031

What are the key factors driving the demand for viral clearance services?

Rise in investment in biological testing and surge in production of biologics

Which was the major region in the global viral clearance service landscape in 2022?

North America was the leading region in 2022

Who are the prominent viral clearance service providers?

Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA, WuXi AppTec, Clean Cells, and Vironova Biosafety AB

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Viral Clearance Service Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Viral Clearance Service Market Analysis and Forecast, 2017-2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Viral Clearance Service Market Analysis and Forecast, by Method

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Method, 2017-2031

        6.3.1. Viral Removal

        6.3.2. Viral Inactivation

            6.3.2.1. Chemical

            6.3.2.2. Radiation

            6.3.2.3. Others

    6.4. Market Attractiveness Analysis, by Method

7. Global Viral Clearance Service Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Application, 2017-2031

        7.3.1. Recombinant Proteins

        7.3.2. Tissue and Blood-derived Products

        7.3.3. Vaccines

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Viral Clearance Service Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2017-2031

        8.3.1. Biopharmaceuticals

        8.3.2. Contract Research Organizations

        8.3.3. Academic Research Institutes

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Viral Clearance Service Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017-2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Viral Clearance Service Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Method, 2017-2031

        10.3.1. Viral Removal

        10.3.2. Viral Inactivation

            10.3.2.1. Chemical

            10.3.2.2. Radiation

            10.3.2.3. Others

    10.4. Market Value Forecast, by Application, 2017-2031

        10.4.1. Recombinant Proteins

        10.4.2. Tissue and Blood-derived Products

        10.4.3. Vaccines

        10.4.4. Others

    10.5. Market Value Forecast, by End-user, 2017-2031

        10.5.1. Biopharmaceuticals

        10.5.2. Contract Research Organizations

        10.5.3. Academic Research Institutes

        10.5.4. Others

    10.6. Market Value Forecast, by Country, 2017-2031

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis

        10.7.1. By Method

        10.7.2. By Application

        10.7.3. By End-user

        10.7.4. By Country

11. Europe Viral Clearance Service Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Method, 2017-2031

        11.3.1. Viral Removal

        11.3.2. Viral Inactivation

            11.3.2.1. Chemical

            11.3.2.2. Radiation

            11.3.2.3. Others

    11.4. Market Value Forecast, by Application, 2017-2031

        11.4.1. Recombinant Proteins

        11.4.2. Tissue and Blood-derived Products

        11.4.3. Vaccines

        11.4.4. Others

    11.5. Market Value Forecast, by End-user, 2017-2031

        11.5.1. Biopharmaceuticals

        11.5.2. Contract Research Organizations

        11.5.3. Academic Research Institutes

        11.5.4. Others

    11.6. Market Value Forecast, by Country/Sub-region, 2017-2031

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Method

        11.7.2. By Application

        11.7.3. By End-user

        11.7.4. By Country/Sub-region

12. Asia Pacific Viral Clearance Service Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Method, 2017-2031

        12.3.1. Viral Removal

        12.3.2. Viral Inactivation

            12.3.2.1. Chemical

            12.3.2.2. Radiation

            12.3.2.3. Others

    12.4. Market Value Forecast, by Application, 2017-2031

        12.4.1. Recombinant Proteins

        12.4.2. Tissue and Blood-derived Products

        12.4.3. Vaccines

        12.4.4. Others

    12.5. Market Value Forecast, by End-user, 2017-2031

        12.5.1. Biopharmaceuticals

        12.5.2. Contract Research Organizations

        12.5.3. Academic Research Institutes

        12.5.4. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017-2031

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis

        12.7.1. By Method

        12.7.2. By Application

        12.7.3. By End-user

        12.7.4. By Country/Sub-region

13. Latin America Viral Clearance Service Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Method, 2017-2031

        13.3.1. Viral Removal

        13.3.2. Viral Inactivation

            13.3.2.1. Chemical

            13.3.2.2. Radiation

            13.3.2.3. Others

    13.4. Market Value Forecast, by Application, 2017-2031

        13.4.1. Recombinant Proteins

        13.4.2. Tissue and Blood-derived Products

        13.4.3. Vaccines

        13.4.4. Others

    13.5. Market Value Forecast, by End-user, 2017-2031

        13.5.1. Biopharmaceuticals

        13.5.2. Contract Research Organizations

        13.5.3. Academic Research Institutes

        13.5.4. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017-2031

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis

        13.7.1. By Method

        13.7.2. By Application

        13.7.3. By End-user

        13.7.4. By Country/Sub-region

14. Middle East & Africa Viral Clearance Service Market Analysis and Forecast

    14.1. Introduction

    14.2. Key Findings

    14.3. Market Value Forecast, by Method, 2017-2031

        14.3.1. Viral Removal

        14.3.2. Viral Inactivation

            14.3.2.1. Chemical

            14.3.2.2. Radiation

            14.3.2.3. Others

    14.4. Market Value Forecast, by Application, 2017-2031

        14.4.1. Recombinant Proteins

        14.4.2. Tissue and Blood-derived Products

        14.4.3. Vaccines

        14.4.4. Others

    14.5. Market Value Forecast, by End-user, 2017-2031

        14.5.1. Biopharmaceuticals

        14.5.2. Contract Research Organizations

        14.5.3. Academic Research Institutes

        14.5.4. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017-2031

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis

        14.7.1. By Method

        14.7.2. By Application

        14.7.3. By End-user

        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2022)

    15.3. Company Profiles

        15.3.1. Texcell

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Eurofins Scientific SE

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Charles River Laboratories International, Inc.

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Merck KGaA

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. WuXi AppTec

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. Clean Cells

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Vironova Biosafety AB

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

List of Tables

Table 01: Global Viral Clearance Service Market Size (US$ Mn) Forecast, by Method, 2017-2031

Table 02: Global Viral Clearance Service Market Size (US$ Mn) Forecast, by Application, 2017-2031

Table 03: Global Viral Clearance Service Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 04: Global Viral Clearance Service Market Size (US$ Mn) Forecast, by Region, 2017-2031

Table 05: North America Viral Clearance Service Market Size (US$ Mn) Forecast, by Country, 2017-2031

Table 06: North America Viral Clearance Service Market Size (US$ Mn) Forecast, by Method, 2017-2031

Table 07: North America Viral Clearance Service Market Size (US$ Mn) Forecast, by Application, 2017-2031

Table 08: North America Viral Clearance Service Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 09: Europe Viral Clearance Service Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 10: Europe Viral Clearance Service Market Size (US$ Mn) Forecast, by Method, 2017-2031

Table 11: Europe Viral Clearance Service Market Size (US$ Mn) Forecast, by Application, 2017-2031

Table 12: Europe Viral Clearance Service Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 13: Asia Pacific Viral Clearance Service Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 14: Asia Pacific Viral Clearance Service Market Size (US$ Mn) Forecast, by Method, 2017-2031

Table 15: Asia Pacific Viral Clearance Service Market Size (US$ Mn) Forecast, by Application, 2017-2031

Table 16: Asia Pacific Viral Clearance Service Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 17: Latin America Viral Clearance Service Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 18: Latin America Viral Clearance Service Market Size (US$ Mn) Forecast, by Method, 2017-2031

Table 19: Latin America Viral Clearance Service Market Size (US$ Mn) Forecast, by Application, 2017-2031

Table 20: Latin America Viral Clearance Service Market Size (US$ Mn) Forecast, by End-user, 2017-2031

Table 21: Middle East & Africa Viral Clearance Service Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Middle East & Africa Viral Clearance Service Market Size (US$ Mn) Forecast, by Method, 2017-2031

Table 23: Middle East & Africa Viral Clearance Service Market Size (US$ Mn) Forecast, by Application, 2017-2031

Table 24: Middle East & Africa Viral Clearance Service Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Viral Clearance Service Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031

Figure 02: Global Viral Clearance Service Market Revenue (US$ Mn), by Method, 2022

Figure 03: Global Viral Clearance Service Market Value Share, by Method, 2022

Figure 04: Global Viral Clearance Service Market Revenue (US$ Mn), by Application, 2022

Figure 05: Global Viral Clearance Service Market Value Share, by Application, 2022

Figure 06: Global Viral Clearance Service Market Revenue (US$ Mn), by End-user, 2022

Figure 07: Global Viral Clearance Service Market Value Share, by End-user, 2022

Figure 08: Global Viral Clearance Service Market Value Share, by Region, 2022

Figure 09: Global Viral Clearance Service Market Value (US$ Mn) Forecast, 2023-2031

Figure 10: Global Viral Clearance Service Market Value Share Analysis, by Method, 2022-2031

Figure 11: Global Viral Clearance Service Market Attractiveness Analysis, by Method, 2023-2031

Figure 12: Global Viral Clearance Service Market Value Share Analysis, by Application, 2022-2031

Figure 13: Global Viral Clearance Service Market Attractiveness Analysis, by Application, 2023-2031

Figure 14: Global Viral Clearance Service Market Value Share Analysis, by End-user, 2022-2031

Figure 15: Global Viral Clearance Service Market Attractiveness Analysis, by End-user, 2023-2031

Figure 16: Global Viral Clearance Service Market Value Share Analysis, by Region, 2022-2031

Figure 17: Global Viral Clearance Service Market Attractiveness Analysis, by Region, 2023-2031

Figure 18: North America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

Figure 19: North America Viral Clearance Service Market Attractiveness Analysis, by Country, 2023-2031

Figure 20: North America Viral Clearance Service Market Value Share Analysis, by Country, 2022-2031

Figure 21: North America Viral Clearance Service Market Value Share Analysis, by Method, 2022-2031

Figure 22: North America Viral Clearance Service Market Value Share Analysis, by Application, 2022-2031

Figure 23: North America Viral Clearance Service Market Value Share Analysis, by End-user, 2022-2031

Figure 24: North America Viral Clearance Service Market Attractiveness Analysis, by Method, 2023-2031

Figure 25: North America Viral Clearance Service Market Attractiveness Analysis, by Application, 2023-2031

Figure 26: North America Viral Clearance Service Market Attractiveness Analysis, by End-user, 2023-2031

Figure 27: Europe Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

Figure 28: Europe Viral Clearance Service Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 29: Europe Viral Clearance Service Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 30: Europe Viral Clearance Service Market Value Share Analysis, by Method, 2022-2031

Figure 31: Europe Viral Clearance Service Market Value Share Analysis, by Application, 2022-2031

Figure 32: Europe Viral Clearance Service Market Value Share Analysis, by End-user, 2022-2031

Figure 33: Europe Viral Clearance Service Market Attractiveness Analysis, by Method, 2023-2031

Figure 34: Europe Viral Clearance Service Market Attractiveness Analysis, by Application, 2023-2031

Figure 35: Europe Viral Clearance Service Market Attractiveness Analysis, by End-user, 2023-2031

Figure 36: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

Figure 37: Asia Pacific Viral Clearance Service Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 38: Asia Pacific Viral Clearance Service Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 39: Asia Pacific Viral Clearance Service Market Value Share Analysis, by Method, 2022-2031

Figure 40: Asia Pacific Viral Clearance Service Market Value Share Analysis, by Application, 2022-2031

Figure 41: Asia Pacific Viral Clearance Service Market Value Share Analysis, by End-user, 2022-2031

Figure 42: Asia Pacific Viral Clearance Service Market Attractiveness Analysis, by Method, 2023-2031

Figure 43: Asia Pacific Viral Clearance Service Market Attractiveness Analysis, by Application, 2023-2031

Figure 44: Asia Pacific Viral Clearance Service Market Attractiveness Analysis, by End-user, 2023-2031

Figure 45: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

Figure 46: Latin America Viral Clearance Service Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 47: Latin America Viral Clearance Service Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 48: Latin America Viral Clearance Service Market Value Share Analysis, by Method, 2022-2031

Figure 49: Latin America Viral Clearance Service Market Value Share Analysis, by Application, 2022-2031

Figure 50: Latin America Viral Clearance Service Market Value Share Analysis, by End-user, 2022-2031

Figure 51: Latin America Viral Clearance Service Market Attractiveness Analysis, by Method, 2023-2031

Figure 52: Latin America Viral Clearance Service Market Attractiveness Analysis, by Application, 2023-2031

Figure 53: Latin America Viral Clearance Service Market Attractiveness Analysis, by End-user, 2023-2031

Figure 54: Middle East & Africa Viral Clearance Service Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

Figure 55: Middle East & Africa Viral Clearance Service Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 56: Middle East & Africa Viral Clearance Service Market Value Share Analysis, by Country/Sub-region, 2022-2031

Figure 57: Middle East & Africa Viral Clearance Service Market Value Share Analysis, by Method, 2022-2031

Figure 58: Middle East & Africa Viral Clearance Service Market Value Share Analysis, by Application, 2022-2031

Figure 59: Middle East & Africa Viral Clearance Service Market Value Share Analysis, by End-user, 2022-2031

Figure 60: Middle East & Africa Viral Clearance Service Market Attractiveness Analysis, by Method, 2023-2031

Figure 61: Middle East & Africa Viral Clearance Service Market Attractiveness Analysis, by Application, 2023-2031

Figure 62: Middle East & Africa Viral Clearance Service Market Attractiveness Analysis, by End-user, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved